Triazolam (Halcion®, Novodorm®, Songar®) belongs to benzodiazepine group of drugs. It is commonly prescribed for insomnia, and its short half-life (approximately 3 hours) makes it ideal for this use because it thereby avoids morning drowsiness.
Questions exist about its safety because it has a fairly narrow therapeutic window. Also, some have suggested that it causes hallucinations, amnesia, paranoia and verbal and physical aggression.
On October 2, 1991, the Committee on the Safety of Medicines (CSM) banned sales of Triazolam in the UK after concluding that it had a higher frequency of psychiatric side-effects than other hypnotics (sleeping pills).
External links
Last updated: 08-11-2005 16:08:24
Last updated: 09-12-2005 02:39:13
